SureScripts Press Release
During the annual HIMSS meeting, SureScripts, LLC announced its safe Rx awards. Their awards are based on the use of e-prescribing as a fraction of total scripts eligible for electronic routing. This is defined as true digital communication between prescriber and pharmacy - not faxing.
As the release points out, "There remains a sizable opportunity to increase the adoption and utilization of e-prescribing across the country – including in all the top 10 Safe-Rx states."
What this means is that the actual number of e-prescriptions is relatively small. One concern is that many prescribers use e-Rx software to write scripts but the transmission to pharmacies remains via fax. The unknown: what percentage of the claimed safety and financial benefits are realized when scripts are written using digital systems but faxed? Given the relative lack of integrated, interoperable systems, it is highly likely that many of the safety and financial benefits will not be realized until pharmacy, medical practice, and data integrator systems (including laboratory systems) are all tightly coupled and focused on comprehensive review and interaction checking.
As the release points out, "There remains a sizable opportunity to increase the adoption and utilization of e-prescribing across the country – including in all the top 10 Safe-Rx states."
What this means is that the actual number of e-prescriptions is relatively small. One concern is that many prescribers use e-Rx software to write scripts but the transmission to pharmacies remains via fax. The unknown: what percentage of the claimed safety and financial benefits are realized when scripts are written using digital systems but faxed? Given the relative lack of integrated, interoperable systems, it is highly likely that many of the safety and financial benefits will not be realized until pharmacy, medical practice, and data integrator systems (including laboratory systems) are all tightly coupled and focused on comprehensive review and interaction checking.
0 Comments:
Post a Comment
<< Home